AI assistant
Sending…
AMGEN INC — Director's Dealing 2019
Nov 8, 2019
29819_dirs_2019-11-07_5cc8dba2-6c4f-4f02-9274-636788186d3f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2019-11-06
Reporting Person: Williams R Sanders (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-06 | Common Stock | S | 425 | $215.45 | Disposed | 5413 | Direct |
Footnotes
F1: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.
More from AMGEN INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 1
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7